Barclays’s BioLife Solutions BLFS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$574K Sell
30,065
-34,029
-53% -$752K ﹤0.01% 3108
2025
Q4
$1.55M Buy
64,094
+9,792
+18% +$256K ﹤0.01% 3110
2025
Q3
$1.39M Sell
54,302
-19,727
-27% -$468K ﹤0.01% 3159
2025
Q2
$1.59M Buy
74,029
+25,648
+53% +$578K ﹤0.01% 3030
2025
Q1
$1.11M Sell
48,381
-17,754
-27% -$468K ﹤0.01% 3046
2024
Q4
$1.72M Buy
66,135
+1,712
+3% +$42.6K ﹤0.01% 3006
2024
Q3
$1.61M Buy
64,423
+10,803
+20% +$255K ﹤0.01% 3029
2024
Q2
$1.15M Buy
53,620
+5,566
+12% +$108K ﹤0.01% 2516
2024
Q1
$891K Sell
48,054
-47,034
-49% -$822K ﹤0.01% 3211
2023
Q4
$1.55M Buy
95,088
+38,120
+67% +$486K ﹤0.01% 3117
2023
Q3
$787K Buy
56,968
+38,311
+205% +$604K ﹤0.01% 2502
2023
Q2
$412K Buy
18,657
+1,197
+7% +$25.2K ﹤0.01% 2878
2023
Q1
$380K Buy
17,460
+1,050
+6% +$23.6K ﹤0.01% 3450
2022
Q4
$299K Buy
16,410
+7,593
+86% +$157K ﹤0.01% 3629
2022
Q3
$201K Sell
8,817
-851
-9% -$18.2K ﹤0.01% 3205
2022
Q2
$133K Sell
9,668
-11,130
-54% -$163K ﹤0.01% 3647
2022
Q1
$472K Buy
20,798
+5,495
+36% +$145K ﹤0.01% 2947
2021
Q4
$570K Sell
15,303
-17,626
-54% -$756K ﹤0.01% 3147
2021
Q3
$1.39M Buy
32,929
+29,840
+966% +$1.44M ﹤0.01% 2578
2021
Q2
$137K Sell
3,089
-14,431
-82% -$508K ﹤0.01% 3715
2021
Q1
$630K Buy
17,520
+12,981
+286% +$513K ﹤0.01% 3057
2020
Q4
$181K Sell
4,539
-1,755
-28% -$59.8K ﹤0.01% 3815
2020
Q3
$182K Buy
6,294
+2,276
+57% +$49.2K ﹤0.01% 3908
2020
Q2
$66K Buy
4,018
+1,577
+65% +$21.7K ﹤0.01% 4781
2020
Q1
$23K Sell
2,441
-4,819
-66% -$66.2K ﹤0.01% 5591
2019
Q4
$117K Buy
7,260
+401
+6% +$6.52K ﹤0.01% 5387
2019
Q3
$114K Sell
6,859
-3,791
-36% -$71.1K ﹤0.01% 5377
2019
Q2
$181K Sell
10,650
-34,463
-76% -$601K ﹤0.01% 5204
2019
Q1
$807K Sell
45,113
-27,787
-38% -$442K ﹤0.01% 3644
2018
Q4
$877K Buy
72,900
+72,500
+18,125% +$866K ﹤0.01% 3261
2018
Q3
$7K Buy
+400
New +$7.91K ﹤0.01% 6717

Other funds holding BLFS